Companies
ITM
the world's leading supplier of non-carrier-added Lutetium-177, with a Lu-177 manufacturing collaboration with the Institut Laue-Langevin dating to 2009 and a fresh 2026 supply agreement with Radiopharm Theranostics.
- Country
- Germany
isotope-supply
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | €188 million venture round in 2024 (2024-06-01) | globenewswire.com |
| Production site | NOVA facility in Neufahrn, Germany (world's largest Lu-177 production site) (2024-01-04) | itm-radiopharma.com |
| Production site | IAZ facility in Garching, Germany (2022-10-13) | biospace.com |
| Revenue | $380 million in 2024 (2024-12-31) medium confidence | compworth.com · privco.com |
| Regulatory approval | Radioactive Material Handling License (RAM License) for NOVA facility (2024-01-04) | ans.org · itm-radiopharma.com |
| Certification | GMP standards compliant (EndolucinBeta) (2023-01-01) | itm-radiopharma.com |
| Capacity | Multiplied capacity with new IAZ production line; NOVA facility capacity can serve up to several hundred thousand patients annually (2022-10-13) | biospace.com |
Independent sources: ans.org · biospace.com · compworth.com · globenewswire.com · itm-radiopharma.com · privco.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Radiopharmaceuticals & theranostics | therapeutics-platforms | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.